Tailored Information About the Coronavirus for Patients With Chronic Kidney Disease (TICCKD)

Ivar Anders Eide

Status: Unknown

Conditions: Renal Insufficiency, Chronic

Treatments: Behavioral: Tailored information

Study type: Interventional

Funder types: Other

Identifiers

NCT04854382

REK 144084/2020

Details and patient eligibility

About

Randomized clinical trial focusing on the effect of tailored information on Covid-19 for patients with chronic kidney disease stage 5 on health literacy, anxiety and self-perceived health.

Full description

This single-center randomized open clinical trial in persons with chronic kidney disease stage 5 investigates the effect of information about coronavirus targeted at the study population, using study specific information videos followed by a teach-back method. We measure digital, functional, interactive and critical health literacy, fear of coronavirus and self-perceived health at baseline and end-of-study. Patients are followed from May-July 2021 through February 2022 (study period 7-9 months).

Enrollment: 215 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Chronic kidney disease stage 5

Exclusion criteria

• Covid-19 during last 12 months. Dementia or other reason why cannot participate like major depression, psychosis or hospitalized persons with severe frailty.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

215 participants in 2 patient groups

Intervention group

Active Comparator group

Description:

Tailored information about coronavirus using information videos followed by a teach-back procedure

Treatment:

Behavioral: Tailored information

Control group

No Intervention group

Description:

Controls have access to information videos, but do not receive the teach-back procedure (the intervention)